Kevin Slater

Kevin Slater

Kevin Slater

CEO And Founder, Praecis Dx Ltd
CEO, previously founded and exited two biotech companies, LumiTech and PetScreen. LumiTech was sold to the Cambrex Corp, in 2000. He is author of six international patents for novel testing methods which now belong to Lonza. PetScreen was a company identifying novel biomarkers associated with acute and chronic veterinary disease also provided resultant novel testing services based on these biomarkers to vets in practice. He is a pioneer of combining multiple biomarker tests using algorithms for the veterinary sector. PetScreen was sold to Avacta Animal Health in 2013. Dr Slater was the Chief Scientific Officer for Avacta until October 2017.

Sponsors & Partners

Education Partners

  • RVC
  • BVA

Platinum Sponsors

  • IVC
  • Hills
  • Idexx
  • humm
  • Vets4Pets
  • Virbac
  • Zoetis

Gold Sponsors

  • Elanco
  • Pioneer

Silver Sponsors

  • Medivet
  • MWI
  • GreenCross
  • iM3
  • Petsapp
  • Lintbells

Wet Lab Partner

  • Central CPD

Media Partners

  • Vet Record
  • Vet Times
  • InPractice
  • Vet Nurse Times
  • VetFile
  • Vet Times Jobs
  • VBJ
  • VetSurgeon


Be the first to hear the latest news, programme updates and exclusive industry releases.